| Stimulant |
Assessment point |
Status of priming |
HIV-1 positive |
HIV negative |
Community controls |
||||
| Fe pos (Sgr I) n = 54 |
Fe neg (Sgr II) n = 54 |
Fe pos (Sgr III) |
Fe neg (Sgr IV) |
(Sgr V) |
|||||
| Category of ARI on follow up |
Category of ARI on follow up |
|
|
|
|||||
| PT n = 38 |
non-PT n = 16 |
PT n = 10 |
non-PT n = 44 |
n = 30 |
n = 50 |
n = 40 |
|||
| PMA |
En |
Unpr |
1.2 ± 2.0‽‡ |
2.6 ± 2.1‽ |
2.4 ± 0.9‽ |
4.3 ± 1.2‽ |
1.6 ± 1.4‽ |
7.4 ± 1.2 |
8.6 ± 1.8 |
| Pr |
1.6 ± 1.8 |
2.8 ± 1.3 |
10.4 ± 4.8† |
12.2 ± 6.8† |
1.8 ± 1.4 |
14.8 ± 4.2† |
18.6 ± 4.8† |
||
| Fu |
Unpr |
1.9 ± 2.1‽‡ |
3.2 ± 1.8‽ |
3.2 ± 1.2‽ |
4.4 ± 0.8‽ |
NA |
NA |
NA |
|
| Pr |
9.1 ± 1.9†* |
12.4 ± 1.5†* |
11.2 ± 3.8† |
12.4 ± 6.1† |
NA |
NA |
NA |
||
| SAC |
En |
Unpr |
4.8 ± 2.6‽‡ |
8.4 ± 4.2‽ |
5.4 ± 3.6‽ |
7.8 ± 4.2‽ |
4.2 ± 2.9‽ |
72 ± 32.4 |
88 ± 22.4 |
| Pr |
5.2 ± 3.2 |
9.6 ± 5.1 |
56 ± 12.8† |
134 ± 38.8† |
5.1 ± 3.8 |
134 ± 42.6† |
148 ± 32.6† |
||
| Fu |
Unpr |
7.2 ± 3.6‽ |
10.2 ± 4.1‽ |
8.6 ± 4.2‽ |
10.2 ± 5.4‽ |
NA |
NA |
NA |
|
| Pr |
58.8 ± 20.2†* |
78 ± 16.2†* |
68 ± 12.8† |
144 ± 18.2† |
NA |
NA |
NA |
||